GOLDMAN SACHS GROUP INC - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 396 filers reported holding SEATTLE GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$192,020,000
+36.2%
981,243
+18.3%
0.06%
+31.0%
Q2 2020$140,983,000
+32.4%
829,705
-10.1%
0.04%
+10.5%
Q1 2020$106,467,000
+26.0%
922,749
+24.7%
0.04%
+72.7%
Q4 2019$84,526,000
+60.7%
739,768
+20.1%
0.02%
+46.7%
Q3 2019$52,600,000
+4.5%
615,917
-15.3%
0.02%
+7.1%
Q2 2019$50,342,000
-19.3%
727,386
-14.6%
0.01%
-26.3%
Q1 2019$62,351,000
-16.0%
851,325
-35.0%
0.02%
-20.8%
Q4 2018$74,213,000
-43.7%
1,309,792
-23.4%
0.02%
-29.4%
Q3 2018$131,807,000
-32.1%
1,709,109
-41.6%
0.03%
-35.8%
Q2 2018$194,139,000
+16.1%
2,924,217
-8.4%
0.05%
+23.3%
Q1 2018$167,180,000
+26.5%
3,194,102
+29.3%
0.04%
+34.4%
Q4 2017$132,139,000
+88.9%
2,469,888
+92.1%
0.03%
+88.2%
Q3 2017$69,938,000
+17.7%
1,285,397
+11.9%
0.02%
+13.3%
Q2 2017$59,430,000
-11.0%
1,148,615
+8.2%
0.02%
-16.7%
Q1 2017$66,759,000
+29.2%
1,062,020
+8.4%
0.02%
+28.6%
Q4 2016$51,691,000
-29.1%
979,555
-27.5%
0.01%
-36.4%
Q3 2016$72,931,000
+430.3%
1,350,318
+296.8%
0.02%
+450.0%
Q2 2016$13,753,000
-1.7%
340,325
-14.6%
0.00%
-20.0%
Q1 2016$13,987,000
-23.5%
398,616
-2.1%
0.01%
-16.7%
Q4 2015$18,283,000
+155.1%
407,370
+119.2%
0.01%
+200.0%
Q3 2015$7,166,000
-25.5%
185,859
-6.4%
0.00%
-33.3%
Q2 2015$9,614,000
-33.5%
198,635
-51.4%
0.00%
-25.0%
Q1 2015$14,459,000
-10.7%
409,039
-18.8%
0.00%
-20.0%
Q4 2014$16,184,000
-30.4%
503,694
-19.5%
0.01%
-37.5%
Q3 2014$23,257,000
+68.5%
625,523
+73.3%
0.01%
+60.0%
Q2 2014$13,804,000
+7.0%
360,909
+27.4%
0.01%
+25.0%
Q1 2014$12,904,000
-34.8%
283,218
-42.9%
0.00%
-42.9%
Q4 2013$19,793,000
+66.0%
496,201
+82.4%
0.01%
+75.0%
Q3 2013$11,925,000
-38.8%
272,078
-56.1%
0.00%
-42.9%
Q2 2013$19,479,000
+687.3%
619,149
+479.9%
0.01%
+600.0%
Q4 2012$2,474,000
-64.5%
106,776
-58.8%
0.00%
-66.7%
Q3 2012$6,977,000
+252.9%
258,951
+232.6%
0.00%
+200.0%
Q2 2012$1,977,000
-77.3%
77,853
-81.8%
0.00%
-75.0%
Q1 2012$8,715,000427,6350.00%
Other shareholders
SEATTLE GENETICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 57,170$10,013,0005.39%
Boxer Capital, LLC 400,000$70,056,0002.25%
PARTNERS CAPITAL INVESTMENT GROUP, LLP 110,153$19,292,0001.10%
DCF Advisers, LLC 13,300$2,329,0000.96%
XTX MARKETS LLC 2,418$423,0000.87%
FAIRFIELD, BUSH & CO. 15,035$2,633,0000.77%
Parcion Private Wealth LLC 4,520$792,0000.10%
Gulf International Bank (UK) Ltd 26,091$4,569,0000.06%
Princeton Portfolio Strategies Group LLC 1,500$263,0000.05%
Redpoint Investment Management Pty Ltd 2,392$419,0000.04%
View complete list of SEATTLE GENETICS INC shareholders